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It is now recognized that understanding how neuroinflammation affects brain function may provide new
insights intoAlzheimer’s pathophysiology. Tumornecrosis factor (TNF)-a, an inflammatorycytokinemarker,
has been implicated in Alzheimer’s disease (AD), as it can impair neuronal function through suppression of
long-term potentiation. Our study investigated the relationship between cerebrospinal fluid TNF-a and
functional connectivity (FC) in a cohortof 64 older adults (m age¼ 69.76 years; 30 cognitively normal, 34mild
AD). Higher cerebrospinal fluid TNF-a levels were associated with lower FC among brain regions important
for high-level decision-making, inhibitory control, and memory. This effect was moderated by apolipo-
protein E-ε4 (APOE4) status. Graph theory metrics revealed there were significant differences between
APOE4 carriers at the node level, and by diagnosis at the network level suggesting global brain network
dysfunction in participants with AD. These findings suggest proinflammatory mechanisms may contribute
to reduced FC in regions important forhigh-level cognition. Future studies are needed to understand the role
of inflammation on brain function and clinical progression, especially in APOE4 carriers.
 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Beta-amyloid and neurofibrillary tangles are the hallmark fea-
turesofAlzheimer’s pathology.However, it is increasingly recognized
that other pathological insults, such as neuroinflammation, may be
involved in the Alzheimer’s cascade (Ardura-Fabregat et al., 2017;
Bronzuoli et al., 2016; Sweeney et al., 2015). For instance, activation
of neuroinflammatory systems is elevated in Alzheimer’s disease
(AD) relative to normal aging (Breunig et al., 2013; Heneka et al.,
2015). Microglia, astrocytes, and even neurons have been shown to
directly react and contribute to chronic neuroinflammatoryns Neuroimaging and Infor-
ersity of Southern California,
23-442-7246; fax: 323-442-
Inc. This is an open access article uresponses in AD. It has been suggested that astrocyte and microglial
activation may be an early event in the pathophysiology of AD,
occurring even in the absence of focal amyloid-b (Ab) deposition
(Dudal et al., 2004).
Apolipoprotein E-ε4 (APOE4), a major genetic risk factor for late-
onset AD, provides a unique opportunity to evaluate AD risk before
the onset of clinical symptoms. APOE is an important modulator of
immune responses, as evidenced by greater immune activation in
mice lacking APOE (Liu et al., 2015). Particularly, APOE4 has been
shown to promote the strongest proinflammatory effects in mouse
models (Guo et al., 2004; Vitek et al., 2009) with additional evi-
dence that APOE4 transgenic mice show increased susceptibility to
inflammation compared with APOE2 and APOE3 mice (den Hartigh
et al., 2012; Rodriguez et al., 2014; Zhu et al., 2012).
The induction of a microglial neuroinflammatory response re-
sults in the release of various inflammatory mediators including an
array of neurotoxic cytokines (Akiyama et al., 2000; Tan et al., 2002).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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markedlyelevated inpatientswithAD (Alsadanyet al., 2013;Heneka
and O’Banion, 2007; Liu et al., 2014), suggesting a chronic neuro-
inflammatory state that intensifies the secretion of associated cy-
tokines and the duration of the immune response, which together
may impact neuronal health. In fact, TNF-a, a member of the cyto-
kine family, can directly impair neuronal function and suppress
hippocampal long-term potentiation (LTP), a mechanism essential
for memory storage and consolidation (Cunningham et al., 1996;
Tancredi et al., 1992). For instance, young APPV717I transgenic
mice show significantly decreased hippocampal LTP preceding
amyloid plaque deposition (Heneka et al., 2005).
In human studies, elevated glial activation is associated with
increased inflammatory cytokine activity including TNF-a in pa-
tients with mild to moderate dementia compared with healthy in-
dividuals (Cagnin et al., 2001; Paganelli et al., 2002; Tarkowski et al.,
2003). Furthermore, in a neuropsychiatric population, elevated
inflammation, as measured by other cytokines such as TNF-a and C-
reactive protein (CRP) inplasma, has been associatedwithdecreased
cortical-striatal connectivity among those diagnosed as clinically
depressed compared with normal adults (Felger et al., 2016). These
studies suggest that cytokines such as TNF-a may directly impair
neuronal function, either by measurement of LTP suppression or
decreased functional connectivity (FC) and that early focal inflam-
matory events may contribute to neuronal dysfunction well before
cell death. Activated glial cells are believed to modulate synaptic
transmission (Bacci et al., 1999; Eroglu and Barres, 2010), and
conversely, synaptic activity can induce activation of neuroimmune
cells, resulting in neurogenic neuroinflammation (Tian et al., 2012).
Collectively, these studies demonstrate a relationship between
neuroinflammation and neural function, with chronic neuro-
inflammation leading to the loss of synapse associated proteins,
thereby causing neuronal damage (Ma et al., 2014).
Although this evidence implicates a role of neuroinflammation in
AD pathogenesis, little is known about the effect of TNF-a on brain
FC. Large-scale changes in global brain function are known to be
associated with early changes in the AD cascade using resting-state
functional magnetic resonance imaging (rsfMRI) and brain network
connectomics (Damoiseaux et al., 2012; Supekar et al., 2008). AD
pathophysiology has long been associatedwith impaired synchrony
among regions important for cognition. Recently, studies using
rsfMRI in a brain connectomic frameworkhave shownaberrant FC in
the earliest stages of AD, concluding that abnormal FCmay be one of
the earliest indicators of neurodegeneration (Contreras et al., 2017,
2019). The aim of the present study was to first investigate a rela-
tionship between cerebrospinal fluid (CSF) inflammatory marker
TNF-a and rsfMRI FC among our cohort, and, second, determine if
APOE4 carrier status influences this relationship. Last, we hope to
better characterize any differences based on APOE4 carrier status
and clinical diagnosis using graph theory metrics.
2. Materials and methods
2.1. Participants
Our prospective study sample consisted of 64 older participants
who were recruited through the Knight Alzheimer’s Disease
Research Center at Washington University at St. Louis. Study pro-
cedures were approved by the local Institutional Review Board and
performed in accordance with the 1964 Declaration of Helsinki.
Informed consent was obtained from all participants before study
enrollment. Clinical diagnosis for each participant was based on
standard criteria as incorporated in the Uniform Data Set (Morris
et al., 2006). Participants were included based on availability of
T1-weighted MPRAGE scan, rsfMRI scan, and CSF biomarker data.Specifically, there were 91 subjects with available CSF markers. Of
those 91 subjects, 64 had available rsfMRI data. Therefore, we
selected all of the 64 subjects with both CSF markers and rsfMRI to
be included in this study. All biomarker assays and quantitativeMRI
scans were conducted by investigators blinded to the clinical status
of the participant.
2.2. CSF biomarkers and genotyping
2.2.1. Inflammatory markers
Meso Scale Discovery (MSD) multiplex assay was used to deter-
mine CSF levels for TNF-a (Cat. No. K15049G, MSD, Rockville, MD,
USA).
2.2.2. Amyloid-b peptide
Enzyme-linked immunosorbent assay was used to determine
CSF Ab42 in all participants (Cat. No. 81583, Innotest, Belgium).
2.2.3. Tau
MSD assay was used to determine CSF levels of total tau on all
participants (Cat. No. K151LAE, MSD, Rockville, MD, USA), and
enzyme-linked immunosorbent assay was used to determine phos-
phorylated tau (pT181) (Cat. No. 81581, Innotest, Belgium).
2.2.4. APOE genotyping
APOE genotyping was performed (as outlined in Nation et al.
[2019]). Participants with at least one copy of the E4 gene were
considered APOE4 carriers. There were no E2 homozygous or het-
erozygous carriers.
2.3. MRI data acquisition, processing, and analyses
2.3.1. Brain imaging acquisition
All images were obtained on a Siemens TrioTim 3T scanner using
a 20-channel head coil. Anatomical T1-weighted 3D gradient echo
pulse sequence scans were acquiredwith the following parameters:
flip angle¼ 8, TR/TE¼ 2400/3.16ms, FOV 256 256mm, voxel size
was 1.1  1.1  1.2 mm3 isotropic, length of scan ¼ 7.04 minutes.
rsfMRI scans were acquired eyes closed with the following param-
eters: flip angle 90, TR/TE¼ 2200/27ms, FOV 384 384mm, voxel
size: 4 mm3 isotropic, scan time ¼ 6.01 minutes.
2.3.2. Preprocessing and correlation analysis
rsfMRI images were preprocessed using the CONN-toolbox v18a
((Whitfield-Gabrieli and Nieto-Castanon, 2012): http://www.nitrc.
org/projects/conn) in SPM12 for data analysis. The default pre-
processing pipelinewas utilized inwhich case, all functional images
were realigned (motion corrected), centered, slice timeecorrected,
corrected for motion artifacts using the artifact detection tools, and
coregistered to their corresponding structural images. Images were
identified as outliers if the head movement (in direction x, y, z) was
more than 5 standard deviations from the mean intensity of the
entire run, or a 97th percentile threshold. All structural images
were then centered and segmented into cerebrospinal fluid, gray
and white matter, and spatially normalized to the Montreal
Neurological Institute template. Functional images were then
normalized to Montreal Neurological Institute space using the
deformation field from the corresponding structural images and
spatially smoothed to allow for better registration and reduction of
noise using a 6 mm FWHM Gaussian kernel.
After preprocessing, the CompCor strategy (Behzadi et al., 2007)
was implemented to account for white matter and CSF noise using
principal component analysis. The analyses did not include global
signal regression to avoid potential false anticorrelations (Murphy
et al., 2009). Motion parameters, cerebrospinal fluid, and white
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no interest. The mean BOLD signal time course was then extracted
from every ROI and band pass filtered (0.009e0.09 Hz). To define
our ROIs, we used the default-atlas implemented in the CONN
toolbox (v18a) that uses a combination of the Harvard-Oxford atlas
and the AAL atlas as well as a few commonly used ROIs from well-
known networks and areas based of the work of Yeo et al (Yeo et al.,
2011) and excluded cerebellar and primary sensory areas. Pearson’s
correlation coefficients were calculated for all pairwise compari-
sons between ROIs (see supplemental material, Appendix for
complete list of ROIs used).
2.3.3. TNF-a-specific functional connectivity analysis and selection
of seed region
To explore all possible associations between TNF-a and ROI to
ROI functional connections, linear regression was used to compute
the correlation between all pairwise ROIs FC strength and TNF-a.
This allowed us to look at the matrix of effects between using all
ROIs as potential “seeds” and all selected target ROIs while also
correcting for multiple comparisons, using connection-level
threshold (e.g., analysis-level FDR p < 0.05). Based on this anal-
ysis, the seed regionwas defined as the nodewith the strongest link
between all ROIs and TNF-a, revealing the nucleus accumbens
(NAcc). Other regions implicated in AD, such as the hippocampus
and parahippocampus, were not found to be associated with TNF-a
at FDR-corrected p-value < 0.05. In our analysis, we investigated
regions functionally connected to either the L or R NAcc as seed
region as well as investigating regions functionally connected to
both L and R regions, which revealed similar results. Because there
was no prior evidence to suggest left or right NAcc differed in their
functional or anatomical role we chose to report on regions func-
tionally connected to either the L or R NAcc as seed region. Age, sex,
education, and diagnosis were included as model covariates, and all
analyses were FDR-corrected (p < 0.05) for multiple comparisons.
Moderation analysis was carried out using the PROCESS macro
(Hayes, 2017) version 3.1 in SPSS version 25 to assess if the asso-
ciation between TNF-a and FC was moderated by APOE4 status.
2.3.4. Graph-based network analysis
Graph theory metrics including average path length, clustering
coefficient, local efficiency and global efficiency were calculated
using CONN toolbox to characterize the dynamics of FC within our
cohort. These measures were calculated at the node level for our
seed regions (NAcc left and right) as well as at the whole-brain
network level using all ROIs listed in supplemental table 1. A
graph adjacency matrix A (i, j) was computed by thresholding an
ROI-to-ROI correlation matrix r (i, j) for each subject. To obtain a
whole-brain network value for each metric for each subject, we
averaged metric ROI values across the brain for each subject.
Average path length was defined as the average of the shortest
paths between each ROI and all other ROIs in the graph. Clustering
coefficient, a measure of the degree to which nodes in a graph tend
to cluster together, was calculated as the fraction of edges among all
possible edges in the local neighboring subgraph for our seed ROI.
Local efficiency represents a measure of local integration, charac-
terizing the degree of interconnectedness of a node. Global effi-
ciency, a measurement of node centrality within a network
characterizing the global connectedness, was defined as the
average of inverse distances between each ROI and all other ROIs in
the graph. A detailed description of equations for graph theory
metrics can be found at www.nitrc.org/projects/conn.
Partial correlation analysis was used to assess the relationship at
the node level between graph theory metrics and TNF-a levels in
APOE4 carriers and noncarriers and between diagnoses. One-way
ANOVA was used to compare all metrics at the whole-brainnetwork level between both APOE4 carriers and noncarriers as
well as between diagnoses.
Last, the variance, skewness, and kurtosis were calculated to
help characterize the group differences between AD and cognitively
normal (CN) participants for the aforementioned graph theory
metrics. The variance is the expectation of the squared deviation of
the observation from the sample mean and therefore is concerned
with the "spread" of the sample. Skewness is concerned with
symmetry of the sample. A skewness of 0 means complete sym-
metry, a negative skew indicates a left tail, and a positive skew
indicates a longer right tail. Kurtosis was used to measure the
sharpness of the sample peak with higher values indicating a more
well-defined mean and more observations around the tail(s).
Smaller values indicate flatter distributions.
3. Results
3.1. Study participants
64 participants (30 CN, 34 mild AD) were included in this study.
Of the total sample, 59% were men and 55% were APOE4 carriers.
Participants were well educated with an average of 15.19 years of
education. APOE4 carriers had significantly lower Ab42 levels than
noncarriers (p< 0.05), and a nonsignificant trend level difference in
TNF-a (p ¼ 0.08). There were no other significant differences be-
tween APOE4 carriers and noncarriers as indicated in Table 1.
3.2. TNF-a level is negatively correlated with resting-state
functional connectivity
Linear regression was used to assess the association between
higher TNF-a levels and lower FC strength among seed regions and
all pairwise ROIs in all subjects (Fig.1). To further explore the nature
of this relationship, FDR-corrected p-values were plotted on
matrices, split by APOE4 carrier status, revealing a possible E4 effect
on the negative correlation between TNF-a and FC (Fig. 2). Age, sex,
education, and diagnosis were included as covariates. The NAcc was
identified as the key hub region, defined as the node with the
strongest link between all ROIs and TNF-a, as seen in Fig. 1. Specif-
ically, the connectivity between bilateral NAcc and the other 31 in-
dividual cortical regions was the best predictor of TNF-a levels
across participants. Highly connected regions to NAcc included
bilateral posterior middle temporal gyrus (MTG), anterior and pos-
terior superior temporal gyrus, superior temporal gyrus, and tem-
poral pole.
3.3. Moderation effect of APOE4 between TNF-a and FC
Connectivity between NAcc and posterior and anterior MTG had
the strongest relationship with TNF-a (p < 0.001). APOE4 was a
significant moderator of the relationship between lower FC and
higher TNF-a levels. Fig. 2 helps visualize the moderating effect that
APOE4 carriers has as seen by the FDR-corrected p-values along the
NAcc column. Specifically, the presence of APOE4 allele moderated
the relationship between TNF-a levels and FC in NAcc and posterior
MTG (APOE4 carriers: TNF-⍺ b¼1.94, t (51)¼4.88, p¼ 0.00001)
and NAcc and anterior MTG (APOE4 carriers, TNF-⍺ b ¼ 1.96, t
(51) ¼ 4.12, p ¼ 0.0001) (Fig. 3).
3.4. Graph theory metrics at the ROI level show differences between
APOE4 carriers and noncarriers
Graph theory metrics for clustering coefficient, average path
length, global efficiency, and local efficiency were calculated with
the left and right NAcc to characterize the broader ROI connectivity
Table 1
Demographics for the study participants
Demographics ALL-median (IQR) APOE4 carriers (n ¼ 34) APOE4 noncarriers (n ¼ 29)
AD CN AD CN
Age (y)b 70.57 (12.93) 75.23 (7.97) 68.05 (16.59) 76.27 (11.50) 64.88 (18.08)
Sex (m/f)a,b 37/26 11/7 9/7 10/5 7/7
Education (y) 16 (5.5) 16 (5) 14 (2.5) 14 (5.25) 16 (2)
Diagnosis (AD/control)a 33/30 18 16 15 14
MMSEb 28 (5) 25.5 (4.5) 29 (2) 27 (7.5) 30 (1)
CDR score (0/0.5/1)a 30/25/8 1/13/4 15/1/0 0/11/4 14/0/0
Ab-42 pg/mLa,c,e 529.667 (312.94) 319.45 (235.74) 581.07 (278.07) 505.19 (265.59) 643.08 (139.18)
T-Tau pg/mLa,b,d 361.9 (412.51) 553.18 (373.03) 309.51 (292.43) 468.25 (349.98) 202.99 (91.26)
P-Tau pg/mL 61.892 (43.87) 78.18 (69.38) 60.45 (34.68) 72.56 (46.29) 49.13 (24.74)
TNF-⍺ pg/mLe 0.0939 (0.0809) 0.107 (0.081) 0.11 (0.114) 0.09 (0.0518) 0.0806 (0.0275)
Significance was tested using Mann-Whitney test.
Key: Ab, amyloid-b; AD, Alzheimer’s disease; APOE4, apolipoprotein E-ε4; CN, cognitively normal; TNF-a, tumor necrosis factor-alpha.
a indicates significant difference between APOE4 carrier groups.
b indicates significant difference between AD/CN groups.
c indicates significant differences between APOE4 carrier versus noncarrier subgroups of AD group.
d indicates significant differences between APOE4 carrier versus non-carrier subgroups of CN group.
e indicates significant difference between CN in APOE4 carrier group and AD in APOE4 noncarrier group. APOE4 þ participants carried a genotype of APOE3/4. APOE4-
participants carried a genotype of APOE3/3.
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NAcc were negatively correlated with TNF-⍺ levels only in APOE4
carriers (R2 ¼ 0.14, b-coefficient ¼ 1.30, p ¼ 0.04; R2 ¼ 0.15, b-
coefficient ¼ 1.21, p ¼ 0.03) (Fig. 4). Global efficiency and average
path length were not correlated with TNF-⍺ levels both when
stratifying by APOE4 status.Fig. 1. Association between TNF-a and FC. Higher TNF-⍺ levels were correlated with lower
involved in memory, visual processing, and language. (A) Connectogramwith blue lines repre
Opacity and width of line are proportional to FDR-corrected p-value. (B) Results are visualized
indicate significant ROIs (saturation of blue spheres proportional to p-value). Abbreviati
accumbens.3.5. Graph theory metrics at the whole-brain network level show
differences based on clinical diagnosis
Clustering coefficient, average path length, global efficiency,
and local efficiency were calculated on a whole-brain network
level for each participant. A significant difference was foundFC between NAcc (important for decision-making and inhibitory control) and regions
senting significant negative correlations between seed and targets after FDR correction.
anatomically on a brain. Red spheres indicate the NAcc as seed region and blue regions
ons: TNF-a, tumor necrosis factor-alpha; FC, functional connectivity; NAcc, nucleus
Fig. 2. Two-sided p-value matrices separated by APOE4 carrier status. Matrices, split by APOE4 carrier status, show FDR-corrected p-values of linear regression model to show the
relationship between TNF-a levels and FC values of ROIs. Connectivity between left and right NAcc and 31 individual cortical regions was significantly associated with TNF-a levels
in APOE4 carriers (A) relative to noncarriers (B) as visualized by the darker red color. Age, sex, education, and diagnosis were included as covariates. Columns represent seed regions;
rows represent projection regions. Abbreviations: APOE4, apolipoprotein E-ε4; TNF-a, tumor necrosis factor-alpha; FC, functional connectivity; NAcc, nucleus accumbens.
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measuring whole-brain network characteristics (Table 2). Specif-
ically, global efficiency was higher, whereas local efficiency, clus-
tering coefficient, and average path length of the whole-brain
network among AD individuals was lower compared with CN
participants. In addition, for each metric, whole-brain network
visualizations were plotted allowing for further observationsFig. 3. Moderation analysis. APOE4 carrier status moderates the relationship between TNF-
anterior MTG (aMTG). APOE4 carriers had a stronger negative association between TNF-a a
APOE4, apolipoprotein E-ε4; TNF-a, tumor necrosis factor-alpha; NAcc, nucleus accumbens.regarding spatial change in network organization as well as
plotting the distribution of values per metric by diagnosis to better
quantify and characterize the change in network organization
(Fig. 5). Variance was calculated to examine the spread of our
sample, skewness to determine the symmetry of the sample/dis-
tribution, and kurtosis to measure the sharpness of the peak of our
distribution (Table 2).a and functional connectivity of the NAcc to (A) left posterior MTG (pMTG) and to (B)
nd FC. Full model estimates are shown from the moderation analysis. Abbreviations:
Fig. 4. Connectivity characteristics of NAcc node correlated with TNF-a only in APOE4 carriers. (A) Local efficiency and (B) clustering coefficient in the right NAcc were negatively
correlated with TNF-⍺ levels. Specifically, the right NAcc showed less integration with its neighboring ROIs and less clustering when TNF-⍺ levels were high. Global efficiency and
average path were not correlated with TNF-⍺. Abbreviations: APOE4, apolipoprotein E-ε4; TNF-a, tumor necrosis factor-alpha; NAcc, nucleus accumbens.
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loss of network organization as you reduce the inherent hierarchy of
nodes (i.e., those acting as hub regions) that is normally present in a
healthy brain and consisted of flatter distributions as indicated by a
smaller kurtosis value (except in the case of global efficiency).
Skewness tended to be more positive in the CN sample, signifying a
greater network organizational structure. The difference in path
lengths between AD and CN was the most visible (Fig. 5D). The CN
group had lengthier paths (>2.72) and fewer shorter paths (<2.23)
comparedwith the AD group. These shorter path lengths among the
AD indicate a less integrated andmoremodular network pointing to
a loss of organization within the AD participants’ network.
Overall, local efficiency and clustering coefficient is disrupted in
APOE4 carriers relative to noncarriers at the ROI level, whereas all
metrics at the global network level were disrupted in AD relative to
CN.
4. Discussion
Our study sought to investigate the relationship between TNF-a,
an inflammatory CSF cytokine relevant to AD, and rsfMRI FC. InTable 2
Connectivity characteristics between CN and AD participants
Measure Group Mean Variance Skewness Kurtosis
Global efficiency CN 0.5009 0.0022 0.698 3.0281
AD 0.5125 0.0017 0.9601 4.0758
Local efficiency CN 0.7139 0.0033 0.3135 3.1841
AD 0.7 0.0023 0.2049 2.9144
Clustering coefficient CN 0.5214 0.0038 0.7414 3.1858
AD 0.4937 0.0025 0.4945 2.7032
Average path length CN 2.2716 0.0303 0.8843 3.2139
AD 2.2031 0.0195 0.7247 3.0054
Bold indicates significance (p < 0.05). There was a significant difference in all graph
theory measures between AD and CN. There was no difference between APOE4
carriers and noncarriers. We averaged metric ROI values across the brain for each
subject to obtain a mean value per diagnosis. Additionally, we used variance,
skewness and kurtosis to better characterize the difference in distributions between
AD and CN for our respective graph theory metrics.
Key: AD, Alzheimer’s disease; APOE4, apolipoprotein E-ε4; CN, cognitively normal.doing so, we identified a functional connectivity network nega-
tively affected by higher TNF-a levels especially among brain re-
gions known to be important in decision-making and inhibitory
control, but with implications for memory, language, and visual
processing. On further analysis, this relationship with TNF-a was
moderated by APOE4 carrier status. Together, these findings sup-
port a heightened proinflammatory environment in APOE4 carriers
that impacts functional connectivity of cognitively meaningful
networks that include brain regions NAcc and MTG.
The NAcc is central in the functional dopaminergic circuit
involving the hippocampus and midbrain and plays a pivotal role in
the formation of spatial memory, formation of novelty and persis-
tent memory traces, as well as promoting reward directed behavior
(Lisman and Grace, 2005; Roy et al., 2016; Russo and Nestler, 2013).
Damage in these areas is presumably the principal cause for the
onset of memory loss and both cognitive and noncognitive hall-
marks of clinical AD (Squire et al., 2004; Wang and Morris, 2010). In
fact, one study implicated that the circuit involving the hippocam-
pus, midbrain and NAcc was severely impaired in an AD mouse
model. This impairment resulted from a degeneration of dopami-
nergic neurons which is essential for correct functioning of the
excitatory synaptic transmission between the NAcc and other re-
gions (Cordella et al., 2018). In further support of the importance of
the NAcc, another study found that atrophy in the NAcc (via reduced
volume) correlatedwith clinical scores such as theMMSE andMOCA
(Nie et al., 2017). Although the studies aforementioned show an
important role of the NAcc in AD, our observations showing the
relevance of NAcc FC in the context of neuroinflammation add new
insight to its role in AD.
MTG has been implicated across many studies to serve a dy-
namic role in cognition, including semantic memory processing
and language (Cabeza and Nyberg, 2000), observation of motion
(Rizzolatti et al., 1996), deductive reasoning (Goel et al., 1998),
dynamic facial expressions (Sato et al., 2012), and multimodal and
higher sensory processing (Mesulam, 1998). Indeed, it has been
proposed that MTG facilitates integration of information between
ventral portions of inferior frontal gyrus and regions in the default
mode network and executive network (Davey et al., 2016).
Therefore, the MTG is spatially well positioned to serve as a hub
Fig. 5. Whole-brain network visualizations and distributions for each metric. Each graph theory metric is represented as a whole brain network between AD participants and CN
participants. ROIs represent spherical nodes where size and color saturation indicate the numerical value of the metric (i.e., lighter color and larger node represent a larger graph
theory metric). (A) Global efficiency values in R and L hemispheres between CN and AD participants. Histogram displays the distribution of the metric by diagnosis. The y-axis
indicates how many nodes fall within a certain metric value. Here we see the difference in distributions between CN and AD. (B) Clustering coefficient, (C) local efficiency, and (D)
average path. Within the AD group overall variance was smaller indicating a smaller spread of values and consisted of flatter distributions as indicated by a smaller kurtosis value
(except in the case of global efficiency). Skewness tended to be greater in the CN sample, indicating a greater network organizational structure (with more high and low values,
indicating the importance of certain nodes as compared with others). CN group had lengthier paths and fewer shorter paths compared with the AD group indicating a less in-
tegrated and more modular network for AD group. These differences in distribution indicate a loss of organization within the AD participants’ network as graph theory metrics show
less variance and narrower distribution reflecting a loss of high and low frequencies. Abbreviations: AD, Alzheimer’s disease; CN, cognitively normal.
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networks. In support of this, a separate study demonstrated the
left MTG as a hub using the participation coefficient (a measure of
the distribution of a node’s edges among the communities of a
network and used to determine a node’s "hubness" (Guimera and
Nunes Amaral, 2005)). This study reported that left MTG mediates
crosstalk between different functional modules in resting-state
networks of those with social anxiety disorder (Yun et al., 2017).
Furthermore, it was presumed that poorer cognitive functioning
and presence of clinical symptoms (Kambeitz et al., 2016; van den
Heuvel and Sporns, 2013; Warren et al., 2014) can result fromlesions within important hub regions such as left MTG (Pannekoek
et al., 2013; Qiu et al., 2014, 2015; Shang et al., 2014). Our results,
showing strong reduced functional connectivity between and
among these 2 important regions lend support to the more “in-
tegrated view” that acknowledges the synergy between different
brain regions, shifting focus from a “neuron-centric” viewwhich is
restricted to local cell dysfunctions (Canter et al., 2016; Palop and
Mucke, 2010).
We also examined the functional characteristics of our seed re-
gion to the entire network using all brain ROIs (Appendix). Because
the NAcc receives information from a variety of systems that
J.A. Contreras et al. / Neurobiology of Aging 86 (2020) 112e122 119promote distinct patterns of behavior, this region may play a more
prominent role in other areas besides reward behavior. Therefore,
we used graph theory metrics computing local, clustering, and
global efficiency, as well as average path length for the left and right
NAcc and overall brain network. We found that the right NAcc
showed reduced local efficiency and clustering in APOE4 carriers
with higher inflammation as measured by TNF-a. This suggests that
the rightNAcc showed less integrationwith its neighboringROIs and
less clustering when TNF-a levels were high. Global efficiency and
average path length for NAcc were not correlated with TNF-a. The
NAcc serves as a critical nodewithin the brain’s reward circuitry; yet,
a more integrated role for this seed region proposed by Mogenson
(Mogenson et al., 1993) suggests that the NAcc serves as a limbic-
motor interface. Thus, the NAcc may be important for critical high-
level tasks, including the selection of actions that help facilitate
efficient goal-directed behavior (Floresco, 2015). These goals are set
by frontal and temporal lobe regionswithwhich the NAcc interfaces
(Floresco et al., 1997; Floresco and Phillips, 1999; Ito et al., 2008;
Mannella et al., 2013). Our results contribute to a growing body of
literature that has reported differences between APOE4 carriers and
noncarriers using graph theoretical measures at the ROI level
(Filippini et al., 2009; Goryawala et al., 2014; Wink et al., 2018), and
importantly highlight the relationship between inflammation,
functional connectivity, and APOE4.
Whenwe compared these graph theorymetrics across thewhole
brain between clinical diagnoses (CN vs. AD), we found significant
differences in all measurements, suggesting whole-brain network
breakdown in those with clinical AD relative to CN participants.
Important to note, the topological organization of a network is
directly related to its local and global efficiency (Bullmore and
Sporns, 2009; Rubinov and Sporns, 2010), as both are used to
determine the brain network’s capability of integrating information
effectively. For instance, local efficiency provides an indication of
how effectively information is integrated between immediate
neighbors of a given node, whereas global efficiency provides an
indication of how effectively information is integrated across the
entire network. We found that while the functional network of
participants with AD had a mean global efficiency value that was
higher than our CN group among all ROIs, the number of ROIs with a
high global efficiency valuewas less than that of the CNparticipants.
This would indicate that there are fewer ROIs acting as central hub
regions in the AD group (Buckner et al., 2009; He et al., 2008; Sporns
et al., 2007). Participants with AD also had a greater number of ROIs
with low local efficiency values as well as an overall lower local ef-
ficiency mean. This difference between global and local efficiency
values between AD and CN groups indicates network organizational
changes that may result in inadequate or inefficient transfer of in-
formation between ROIs, which is consistent with “small-world”
organization that reflects the optimal balance between local pro-
cessing and global integration in the human brain (Bassett and
Bullmore, 2016).
Last, taking into consideration both clustering coefficiency and
path length among ROIs, the network of participants with AD was
less integrated and contained a more modular network resulting in
reduced path lengths and lower clustering coefficiency values.
Previous research has shown both resting-state network and
modularity network differences between CN and AD groups and at
various stages along the disease (Contreras et al., 2019; Sanz-Arigita
et al., 2010; Supekar et al., 2008; Tijms et al., 2013;Wang et al., 2010,
2013). These results, taken together, may indicate a possible staging
of early network breakdown at the local network level that is
related to inflammation and that whole brain network breakdown
follows along the spectrum of clinical disease.
Consistent with our findings, other studies have demonstrated
higher inflammation and decreased functional connectivity inother patient populations. For instance, patients with major
depressive disorder had reliably elevated cytokine levels,
including CRP, interleukins 6, 1b, and 1 that were associated with
decreased connectivity within striatal reward-related brain re-
gions (i.e., putamen, caudate, and subdivisions on the striatum)
(Felger et al., 2016). Similarly, nonhuman primate work has
demonstrated that chronic administration of inflammatory cyto-
kines decreased striatal dopamine release (Felger et al., 2007;
Felger and Miller, 2012). Therefore, inflammation-related re-
ductions in corticostriatal connectivity, may serve as a new
pathophysiological pathway to explore in an effort to better un-
derstand how inflammation effects brain function and connec-
tivity. Another study measured neuroinflammation via activated
microglia using a PET radioactive tracer and found that AD-related
neuroinflammation in white matter tissue of both mice and
humans was increased compared with control mice (Raj et al.,
2017). Because white matter tracts in the brain can be related to
functional connectivity and speed of processing, compromised
white matter integrity during aging can lead to symptomology
such as compromised cognitive performance, as shown by de
Lange et al (de Lange et al., 2016). They found differences in white
matter integrity correlated to the participants’ ability to adapt to
demands of cognitive tasks and overall memory performance. In
addition to the association between functional brain differences
and inflammation, structural MRI studies have demonstrated a
relationship between MRI markers of brain volume and CSF and
plasma inflammation biomarkers in AD. A study with 42 partici-
pants with AD found a correlation between the CSF/serum IgG
index and the indices of AD severity, including clinical dementia
and medial temporal lobe atrophy (Matsumoto et al., 2008).
Another study identified that 34 MRI volumetric brain regions
(including the hippocampus, cingulate cortex, amygdala, and basal
ganglia) combined with plasma cytokines and chemokines pro-
vided the best predictor of conversion from cognitive impairment
to AD (Furney et al., 2011). Last, higher levels of systemic inflam-
mation have been associated with reduced fractional anisotropy in
white matter and lower cognition (Arfanakis et al., 2013). In a
sample of nondemented older participants, systemic inflamma-
tion, assessed using a composite measure of inflammatory
markers CRP and TNF-a, was found to negatively correlate with
diffusion anisotropy in the corpus collosum and visual cognition
suggesting inflammation is associated with lower microstructural
integrity which leads to impaired higher-order visual cognition in
aging adults. With evidence mounting on the effects of inflam-
mation on large scale brain changes, it has become even more
important to understand the role of inflammation on AD
pathophysiology.
The amyloid cascade hypothesis states that deposition of Ab is
the causative agent of AD and that neurofibrillary tangles, inflam-
mation, cell loss, vascular damage, and cognitive impairment are
downstream effects of Ab, with interactions between events (Hardy
and Higgins, 1992; Selkoe, 1991). Yet, mounting evidence suggests
that neuroinflammation may play a substantial role in Alzheimer’s
pathogenesis. While the interaction and temporal sequence of se-
nile plaques, neurofibrillary tangles, and neuroinflammation
remain inconclusive, animal models suggest neuroinflammation
may contribute to the pathogenesis of plaques and tangles them-
selves (Zhang et al., 2013). This is underlined by findings that genes
for immune receptors, such as TREM2, a microglial activation
marker (Guerreiro et al., 2013) and CD33, also a microglial activa-
tion marker and thought to inhibit Ab clearance (Bradshaw et al.,
2013; Griciuc et al., 2013), are associated with AD. Analysis of
clinical manifestations, which precede AD, such as mild cognitive
impairment, further argues for substantial involvement of inflam-
mation in the pathogenesis of AD.
J.A. Contreras et al. / Neurobiology of Aging 86 (2020) 112e1221204.1. Limitations and future directions
There are limitations to the present study. For instance, wewere
limited in that our APOE4 carriers were all heterogenous E3/4 car-
riers whereas our noncarriers were homozygous E3/3 carriers.
Ideally, wewould have liked to be able to parse out effects for those
that were homozygous for E4 and any protective effects that E2
homozygous and heterozygous might have. It’s also worth noting
that we elected to use a specific brain parcellation scheme that also
identifies ROIs belonging to particular resting state networks . It is
possible that alternative anatomic and functional templates could
return different results. Thus, future studies including multiple
brain parcellation schemes and resting state network definitions
would help determine the validity of our findings. We also
acknowledge that better spatial resolution and improved acquisi-
tion parameters can greatly improve data quality as well as improve
the stability and reproducibility of FC ROI-to-ROI results. Although
this was not possible within this study, owing to the retrospective
nature of the data, future studies will use superior methodology. In
addition, we did not examine the role of other prominent inflam-
matory markers that may be modulating TNF-a such as IL-8, IL-6, as
well as determining if blood-brain barrier (BBB) breakdown in-
fluences these relationships. We also recognize we were limited by
the availability of clinical assessments as is the case with retro-
spective data. As much as 52% of clinical data were either missing,
not collected, or incomplete. However, we are currently collecting
additional data with similar variables (i.e., resting state fMRI data
with advanced acquisition sequences, APOE genotype information
availability, cognitive data) as well as CSF data that include a wide
range of inflammatory markers and markers to measure BBB
breakdown. These data will enable future studies to explore other
markers and better establish a biological pathway for TNF-a (i.e.,
establish if vascular damage, via measuring BBB breakdown, leads
to an increase in inflammatory markers).
In summary, we have provided evidence implicating neuro-
inflammation in APOE4 and AD, showing that higher CSF TNF-a
levels are associated with lower FC between brain regions impor-
tant in decision-making and inhibitory control in APOE4 carriers.
Investigating inflammation and functional connectivity in older
adults at risk for AD may help us better understand how the im-
mune system contributes to the pathogenesis of AD.Disclosure
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